Enterococcus faecium

Vancomycin-resistant Enterococcus faecium (VREF) causes an infection common in US hospitals and is resistant to all commercially available antibiotics. Hospital outbreaks are rare in Europe, although VREF carriage among healthy individuals and livestock is common. A study from the National Institute of Public Health, Bilthoven, Netherlands, published in the online version of the Lancet on 13 March, suggests that genetic screening of E. faecium carriers could help eradicate this infection (Lancet

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Vancomycin-resistant Enterococcus faecium (VREF) causes an infection common in US hospitals and is resistant to all commercially available antibiotics. Hospital outbreaks are rare in Europe, although VREF carriage among healthy individuals and livestock is common. A study from the National Institute of Public Health, Bilthoven, Netherlands, published in the online version of the Lancet on 13 March, suggests that genetic screening of E. faecium carriers could help eradicate this infection (Lancet 2001, 357:853-854).

Willems et al used DNA probes based on the esp virulence gene from E. faecalis, and screened (by Southern blotting) chromosomal digests of 120 VREF isolates associated with hospital outbreaks in the US, Europe and Australia. These were compared with 45 non-epidemic isolates. A particular subpopulation of E. faecium was associated with epidemic outbreaks in all three continents, and these epidemic strains carried a variant of the esp gene. The variant was not present in non-epidemic and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies